asa guidelines for glp-1 GLP-1s are changing what we see chairside—and most of us were never taught what to do about it. 🦷⁠ ⁠ Dry mouth. Increased caries risk. Muscle loss. Nutrient deficiencies. Reflux. Your patients Glucagon‐like peptide‐1 receptor agonists: a

Einarson MB (2001) Detection of Protein-Protein Interactions Using the GST Fusion Protein Pulldown Technique

One in three Canadians are currently living with obesity, and in 10 years, that number is going to change to about 50 per cent, so this is really an opportunity for policymakers to take action. LISTEN | WHO conditionally recommends GLP-1 drugs for obesity: The WHOs first conditional recommendation advises the use of GLP-1 drugs by adults, except pregnant women, for long-term obesity treatment, while the second suggests interventions like a healthy diet and physical activity to be offered alongside the medicines

Pan H-Z, Zhang H, Chang D, Li H, Sui H

Both approaches have loyal followers, and the best choice usually depends on how your body reacts to the medication